Paul Tudor Jones's CMPX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 88,931 shares of Compass Therapeutics, Inc. (CMPX) worth $470,445, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in CMPX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Compass Therapeutics (CMPX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Compass Therapeutics (CMPX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +88,931 | New Buy | 88,931 | $5.29 |
Paul Tudor Jones's Compass Therapeutics Investment FAQs
Paul Tudor Jones first purchased Compass Therapeutics, Inc. (CMPX) in Q1 2026, acquiring 88,931 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Compass Therapeutics, Inc. (CMPX) for 1 quarters since Q1 2026.
Paul Tudor Jones's largest addition to Compass Therapeutics, Inc. (CMPX) was in Q1 2026, adding 88,931 shares worth $470,445.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 88,931 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $470,445.
As of the Q1 2026 filing, Compass Therapeutics, Inc. (CMPX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Compass Therapeutics, Inc. (CMPX) was 88,931 shares, as reported at the end of Q1 2026.